Caption Management, LLC Halozyme Therapeutics, Inc. Transaction History

Caption Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $1.06 Million - $1.42 Million	27,500 New	27,500 $1.09 Million
Q4 2019 Feb 13, 2020	BUY	$14.93 - $19.53 $228,429 - $298,809	15,300 Added 40.05%	53,500 $949,000
Q3 2019 Nov 14, 2019	BUY	$15.2 - $17.69 $580,640 - $675,758	38,200 New	38,200 $593,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.